Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 0.1236 USD 3% Market Closed
Market Cap: 17.8m USD

Intrinsic Value

The intrinsic value of one APLT stock under the Base Case scenario is 4.5992 USD. Compared to the current market price of 0.1236 USD, Applied Therapeutics Inc is Undervalued by 97%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

APLT Intrinsic Value
4.5992 USD
Undervaluation 97%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare APLT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about APLT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Applied Therapeutics Inc

Current Assets 31.7m
Cash & Short-Term Investments 11.9m
Receivables 16.7m
Other Current Assets 3.1m
Non-Current Assets 2.7m
Long-Term Investments 252k
PP&E 2.5m
Current Liabilities 32.9m
Accounts Payable 4.8m
Accrued Liabilities 23.3m
Other Current Liabilities 4.8m
Non-Current Liabilities 2m
Other Non-Current Liabilities 2m
Efficiency

Free Cash Flow Analysis
Applied Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Applied Therapeutics Inc

Revenue
1m USD
Operating Expenses
-99.4m USD
Operating Income
-98.4m USD
Other Expenses
80.3m USD
Net Income
-18.1m USD
Fundamental Scores

APLT Profitability Score
Profitability Due Diligence

Applied Therapeutics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
ROIC is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
31/100
Profitability
Score

Applied Therapeutics Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

APLT Solvency Score
Solvency Due Diligence

Applied Therapeutics Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Applied Therapeutics Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

Wall Street analysts forecast APLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLT is 1.785 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.

Lowest
Price Target
1.01 USD
717% Upside
Average
Price Target
1.785 USD
1 344% Upside
Highest
Price Target
2.1 USD
1 599% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Applied Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for APLT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

APLT Insider Trading
Buy and sell transactions by insiders